Oncocyte Corp Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Oncocyte Corp quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Oncocyte Corp Return On Assets for the quarter ending June 30, 2024 was -47.8 %, a 14.2% increase year-over-year.
  • Oncocyte Corp annual Return On Assets for 2023 was -34 %, a 33% increase from 2022.
  • Oncocyte Corp annual Return On Assets for 2022 was -50.7 %, a 25.6% decline from 2021.
  • Oncocyte Corp annual Return On Assets for 2021 was -40.4 %, a 20.3% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -34 +16.7 +33% Jan 1, 2023 Dec 31, 2023
2022 -50.7 -10.3 -25.6% Jan 1, 2022 Dec 31, 2022
2021 -40.4 +10.3 +20.3% Jan 1, 2021 Dec 31, 2021
2020 -50.7 +8.33 +14.1% Jan 1, 2020 Dec 31, 2020
2019 -59 +66.5 +53% Jan 1, 2019 Dec 31, 2019
2018 -126 +24.1 +16.1% Jan 1, 2018 Dec 31, 2018
2017 -150 -57.3 -62.1% Jan 1, 2017 Dec 31, 2017
2016 -92.3 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.